Overview Vinorelbine and Gemcitabine in Myeloma Status: Completed Trial end date: 2017-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether the efficacy of gemcitabine is comparable with the efficacy of the standard chemotherapy with vinorelbine for mobilization of autologous stem cells in myeloma patients Phase: Phase 2 Details Lead Sponsor: University Hospital Inselspital, BerneTreatments: GemcitabineVinblastineVinorelbine